ETHYL 3-OXOTETRAHYDRO-2H-PYRAN-4-CARBOXYLATE, 95.0%, 1g

Azido-PEG4-CH2-Boc, 97%, 1g

4-(4-(Benzyloxy)benzyl)piperidine hydrochloride, 97%, 250mg

3-(4-Bromo-2-fluorophenyl)-1-propene, 97.0%, 1g

2-Nitrobenzaldehyde, min. 98%, for synthesis, 250 g, plastic packaging.

2-Acetylaminothiazole, 95.0%, 25g

2-Methoxythiazole, 96.0%, 1g

1-[4-(Aminomethyl)piperidin-1-yl]ethanone hydrochloride, 95.0%, 1g

4,4'-Dimethoxybenzophenone>99.0%(GC)100g

5-Fluoro-2-methylbenzaldehyde, 97.0%, 500g

(R)-(+)-1-(1-Naphthyl)ethylamine>99.0%(GC)1g

1-Acetyl-4-(tert-butoxycarbonyl)piperazine-2-carboxylic acid, 97%, 250mg

N-(3-Aminopropyl)-2-[(3-methylphenyl)methoxy]-N-(2-thienylmethyl)benzamidehydrochloride, 98%, 10mg